Cytokinetics | CYTK - Current Assets


Cytokinetics reported $916.97M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Acadia Pharmaceuticals USD 1.06B 14.31M Dec/2025
Amgen USD 29.06B 1.17B Dec/2025
Arca Biopharma USD 343.86M 11.31M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Brainstorm Cell Therapeutics USD 307K 201K Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Capricor Therapeutics USD 322.94M 221.99M Dec/2025
Cytokinetics USD 916.97M 60.37M Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Exelixis USD 1.44B 41.03M Dec/2025
Geron USD 520.27M 2.07M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
Ligand Pharmaceuticals USD 832.27M 78.35M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Novartis USD 30.46B 2.26B Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025